Luke Buizen
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Opioid Use Disorder Treatment 5
- Acute Lymphoblastic Leukemia research 2
- Oncology 7
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Val Gebski (5 shared papers)Anthony Keech (3 shared papers)Alicia J. Jenkins (3 shared papers)David Sullivan (3 shared papers)Paul Donnellan (6 shared papers)Felix Hilpert (6 shared papers)Rachel O’Connell (6 shared papers)Jonathan S. Berek (6 shared papers)
- Journals
- Gynecologic Oncology (2 papers)Diabetes Obesity and Metabolism (2 papers)Journal of Clinical Oncology (2 papers)Blood (2 papers)JAMA Internal Medicine (1 paper)
- Partner nations
- AustraliaCanadaUnited Kingdom
In The Last Decade
Luke Buizen
25 papers receiving 301 citations
Peers
Comparison fields: 5 of 63
- Reproductive Medicine 58
- Nephrology 38
- Oncology 112
- Hematology 31
- Obstetrics and Gynecology 21
Countries citing papers authored by Luke Buizen
This map shows the geographic impact of Luke Buizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Buizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Buizen more than expected).
Fields of papers citing papers by Luke Buizen
This network shows the impact of papers produced by Luke Buizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Buizen. The network helps show where Luke Buizen may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Buizen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 43 | |
| 2 | 2017 | 33 | |
| 3 | 2021 | 32 | |
| 4 | 2017 | 30 | |
| 5 | 2015 | 25 | |
| 6 | 2015 | 22 | |
| 7 | 2019 | 19 | |
| 8 | 2017 | 18 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2024 | 10 | |
| 12 | 2023 | 8 | |
| 13 | 2022 | 8 | |
| 14 | 2019 | 6 | |
| 15 | 2019 | 6 | |
| 16 | 2014 | 5 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2018 | 3 | |
| 20 | 2021 | 3 |
About Luke Buizen
Luke Buizen is a scholar working on Public Health, Environmental and Occupational Health, Oncology, Reproductive Medicine, Anesthesiology and Pain Medicine and Pediatrics, Perinatology and Child Health, having authored 27 papers that have together received 306 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Opioid Use Disorder Treatment (5 papers), Pain Management and Opioid Use (5 papers), Prenatal Substance Exposure Effects (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Acute Myeloid Leukemia Research (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Reproductive Medicine (58 citations), Nephrology (38 citations), Oncology (112 citations), Hematology (31 citations) and Obstetrics and Gynecology (21 citations). Luke Buizen has collaborated with scholars based in Australia, Canada and United Kingdom. Frequent co-authors include Val Gebski, Anthony Keech, Alicia J. Jenkins, David Sullivan, Paul Donnellan, Felix Hilpert, Rachel O’Connell, Jonathan S. Berek, Aikou Okamoto and Anne Lanceley. Their work appears in journals such as Gynecologic Oncology, Diabetes Obesity and Metabolism, Journal of Clinical Oncology, Blood and JAMA Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.